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given to 46.9% of hospitals reporting the minimum threshold
of 1 Outcome measure group, 31.2% of hospitals reporting 2
Outcome measure groups, and 25.5% of hospitals reporting
all 3 Outcome measure groups (P < .001) (Table). Star ratings
were based on the minimum eligibility threshold of only 3 of
7 measure groups for 49.4% of specialty and 33.3% of critical
access hospitals; whereas, 94.3% of major teaching, 80.8% of
other teaching, and 96% of community hospitals reported all
7 measure groups.
Discussion | Hospitals less frequently received a high star rat-
ing if theywere larger, academichospitals or cared for ahigher
proportion of disproportionate share patients. Specialty and
critical access hospitalsmore frequently earned high star rat-
ings compared with acute care hospitals. Critical access hos-
pitals and some specialty hospitals (ie, certain cancer cen-
ters) are exempt from reporting-based payment incentives
through theCMS InpatientQualityReporting systemandmay
not collect many measures used in the star ratings.4 Conse-
quently, specialty and critical access hospitals reported sys-
tematically fewer measures. Although hospital type influ-
enced the number and type of measures reported, the study
was limited by the inability to determinewhether differences
in individualmeasure reportingbyhospital typeexplained the
differences in star ratings.
Because themeasuresusedas thebasis for calculating the
star ratingsdifferedbyhospital type, failure toaccount for these
differences may limit the utility of the star ratings, particu-
larly when comparing different hospital types.
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COMMENT&RESPONSE
Global Burden of Disease Attributable to
Hypertension
To the Editor The Global Burden of Disease (GBD) project has
made important contributions to the fieldofpublichealth sur-
veillance. However, when providing cause-specific data, the
limitations inherent in global estimates become apparent. In
the article on the global burden of hypertension, an anomaly
is the largenumber of disability-adjusted life-years fromcoro-
nary heart disease assigned to sub-Saharan Africa and many
parts of Asia.1 It is well established that coronary heart dis-
ease remains infrequent to rare insub-SaharanAfricaandmuch
ofAsia.2-5 In thesupplementalmaterial, theauthors stated that
the process of risk estimation was “standardized to enhance
the comparability of results across risks, outcomes, popula-
tions and time,”which implies that the same risk coefficients
were used for calculations in all geographic regions. This
Figure. Mean No. of Hospital QualityMeasures Reported (of 62 Total
PossibleMeasures) by Hospital Typea
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a Error bars represent 95% CIs. Includes hospitals that met the reporting
threshold of at least 3 measures within at least 1 Outcome group (mortality,
readmissions, safety). Using the Kruskal-Wallis test, P<.001 for all pairwise
comparisons except between critical access and specialty hospitals (P = .96).
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method will provide biased estimates of cardiovascular out-
comes; although the relative risksmaybe similar acrosspopu-
lations, the background of other risk factors, such as smoking
andhyperlipidemia, vary andwill influence theevent rate and
the number of deaths from coronary heart disease.5 In popu-
lations like those in sub-Saharan Africa and much of Asia,
serum lipids remain low and, in Africa at least, smoking is
uncommon.2-5 The largepopulation-attributable fractions for
these regions are therefore likely to be overestimates.
In addition,wequestion the reliability of this approach to
surveillancegiven theabsenceof empirical data inmanyof the
countries included. The calculation of events for the cardio-
vascular endpoints requires age- and sex-specific bloodpres-
sures, an appropriate risk coefficient for each disease cat-
egory, andknowledgeof thepopulationsize.Thesedatadonot
exist for countries in sub-Saharan Africa. Regional estimates
were used to impute missing data, but we would argue that
there must be some limits to how far that process can be ex-
tended. The supplemental tables, for example, provide spe-
cificbloodpressurevalues formanycountries fromwhichdata
for either 1990and2015werenil ornonexistent (eg,Myanmar,
North Korea, Syria, Kiribati) and for other countries that did
not exist at the baseline date (eg, Montenegro, South Sudan).
The questionable validity of this approach is apparent in the
implausible results obtained for sub-Saharan Africa. We be-
lieve it is more informative to restrict disease burden esti-
mates to countries fromwhich adequate data are available.
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In ReplyDrCooper and colleagues suggest that coronary heart
disease remains infrequent to rare in sub-Saharan Africa and
Asia.We disagree. The empirical evidence behind their claim
is unclear as they only cite a few older studies.
In contrast, the GBD study relied on a larger andmore re-
cent set of primary sources regarding mortality due to ische-
mic heart disease (IHD) in these regions.1 For sub-Saharan
Africa,weusedvital registrationandverbal autopsydata from
11 countries, which showed the fraction of deaths due to IHD
in sub-Saharan Africa was between 2% and 10% of deaths,
among the lowest in the world but hardly rare. For Asia, the
GBD study added 5million deaths reported annually through
the China Center for Disease Control Cause of Death report-
ing system from2004 through 2014, helping to show that the
fraction of deaths due to IHD varied widely in Asia based on
location, ranging from 5% to 47%.
Cooper and colleagues question whether these effects
are modified by levels of tobacco smoking or serum choles-
terol in a population. We agree that tobacco smoking and
cholesterol levels can modify the effect of elevated systolic
blood pressure (SBP) on IHD, although this effect appears to
be small.3,4 We used estimates of the independent relative
risks of elevated SBP, after adjustment for other risks, to
address this issue.
The GBD study estimated that levels of tobacco smoking
and cholesterol are lower inmost parts of sub-Saharan Africa
compared with other regions of the world, which may par-
tially explain the relatively lower levels of IHD in that region.
In contrast, health surveys performed throughout sub-
Saharan Africa in recent years have not shown significantly
lower levels of SBP compared with other regions. There are
numerous health surveys reporting blood pressure levels in
Africa and Asia, including for many of the countries where
Cooper and colleagues assumed data were unavailable, for
example surveys from Myanmar in 2014 and North Korea
in 2008.
Our findings suggest that elevated SBP is an important
health hazard in many areas of sub-Saharan Africa and Asia.
We disagree that the absence of data from some of these
countries prevents us from producing country-specific esti-
mates because geospatial modeling has a strong empirical
foundation. Cooper and colleagues appear to suggest that
only primary data should be used for global health estima-
tion, and data should only be used just as reported by a
country. Unfortunately, such an approach does not address
some of the most pressing challenges in global health policy,
whereas a model-based approach allows us to evaluate
regional trends and identify diseases, such as cardiovascu-
lar disease, for which surveillance needs to be intensified.
Models of global health burden can include data on risk
exposures such as body weight that are both causal for and
predict elevated SBP among populations. We believe that
with rigorous and transparent evaluation of all sources of
information and quantitative estimates of both predictive
validity and uncertainty, model-derived estimates like those
from the GBD study provide an important platform for inte-
grating all available knowledge on population health. Ongo-
ing efforts to improve these models will be seen in the
annual results produced by the GBD collaboration.
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IntubationDuring In-Hospital Cardiac Arrest
To the Editor In a large retrospective evaluation of intubation
during cardiac arrest, Dr Andersen and colleagues suggested
that intubation during the first 15 minutes of in-hospital car-
diac arrest was associated with decreased survival.1 Al-
though the authors tried to balance thedistribution of groups
with statistical analysis, the original groups were signifi-
cantly different, preventing like groups from being analyzed.
Therewere twice asmanypatients in the intubationgroup
(n = 71 615) than in the no-intubation group (n = 36 464).
As an example of groupdifference, the percentage of patients
in the no-intubation group who received noninvasive as-
sisted ventilation was 22%, compared with only 4% of intu-
bated patients. In addition, patients who were intubated had
a lower percentage of shockable rhythms (15%) compared
with patients who were not intubated (24%). Intuitively, pa-
tients who have shockable rhythms are more likely to con-
vert to a pulsed rhythmwith a higher survival rate and there-
fore do not need intubation. Also, no analysis (P values) was
presented to identify significant differences between the 2
groups. We do not believe the authors achieved their goal of
minimizing selection bias.
Andersen and colleagues attempted to reduce this bias by
propensity score matching2 and presented 2 matched co-
horts inTable 2 in the article. Paradoxically, thenumber in the
matchedno-intubationgroup (n = 43314)washigher than the
total number of patients in the original no-intubation group.
Some of the patients initially in the intubation group appear
to have been included in thematched no-intubation group in
Table 2, which would introduce bias into the analysis.
As Dr Angus alluded to in his Editorial,3 even data sets of
this size are not sufficient to exclude residual confounding.
Based on the data presented, we think that there are suffi-
cient differences between the 2 original groups to doubt the
authors’ conclusions.
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In Reply Dr Wilt and Ms Lee question the validity of our
results due to between-group differences in baseline charac-
teristics before propensity matching, specifically mention-
ing differences in noninvasive ventilation and the initial
rhythm. As noted in Table 2 in the article, these characteris-
tics were well matched in the propensity score–matched
cohort. Therefore, these variables cannot confound the
adjusted results. Furthermore, in our subgroup analysis
according to initial rhythm, intubation was associated with
poor outcomes in both those with initial shockable and non-
shockable rhythms. As noted in the article, there might be
unmeasured confounders we were unable to adjust for.
Wilt and Lee are also concerned about the lack of
P values in Table 1. However, confounding is not related
to statistical significance, and P values can be misleading
with large (or small) sample sizes.1 We therefore provided
standardized differences in Table 2 indicating a well-
balanced cohort.1,2
In addition, Wilt and Lee write, “Paradoxically, the num-
ber in the matched no-intubation group (n = 43 314) was
higher than the total number of patients in the original
no-intubation group.” This is not paradoxical because our
analysis used risk-set matching. As stated in the article, “At-
risk patients included those who were still undergoing resus-
citation and were not intubated before or within the same
minute. At-risk patients therefore also included patients
who were intubated later, as the matching should not be
dependent on future events. As such, the matched group
with no intubation includes patients who subsequently were
intubated (although later than their matched counterpart).”3
In the Figure, 5 hypothetical patients are schematically out-
lined. As an example, patient A who was intubated during
minute 1 could be matched with any patient at risk of being
intubated during minute 1, which includes patients B, C, D,
and E. Patient C, who was intubated during minute 3, could
be matched only with patient B because none of the other
patients were at risk of intubation at this time point. Addi-
tional details and the rationale for this approach are pro-
vided in the supplemental material in the article as well as in
a previous study from our group.4 In brief, this approach is
needed to avoid bias because patients with longer cardiac
arrests are more likely to be intubated. As such, a traditional
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